Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOSIMILAR MONOCLONAL ANTIBODY INDUSTRY
2.1 Summary about Biosimilar Monoclonal Antibody Industry
2.2 Biosimilar Monoclonal Antibody Market Trends
2.2.1 Biosimilar Monoclonal Antibody Production & Consumption Trends
2.2.2 Biosimilar Monoclonal Antibody Demand Structure Trends
2.3 Biosimilar Monoclonal Antibody Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Synthetic Chemicals
4.2.2 Biopharmaceuticals
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Chronic & Autoimmune Diseases
4.3.2 Oncology
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Synthetic Chemicals
5.2.2 Biopharmaceuticals
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Chronic & Autoimmune Diseases
5.3.2 Oncology
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Synthetic Chemicals
6.2.2 Biopharmaceuticals
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Chronic & Autoimmune Diseases
6.3.2 Oncology
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Synthetic Chemicals
7.2.2 Biopharmaceuticals
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Chronic & Autoimmune Diseases
7.3.2 Oncology
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Synthetic Chemicals
8.2.2 Biopharmaceuticals
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Chronic & Autoimmune Diseases
8.3.2 Oncology
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Synthetic Chemicals
9.2.2 Biopharmaceuticals
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Chronic & Autoimmune Diseases
9.3.2 Oncology
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Biocon
10.1.2 Accord Healthcare
10.1.3 AET Biotech
10.1.4 Amgen
10.1.5 Celltrion
10.1.6 Reddy's Laboratories
10.1.7 Hospira
10.1.8 3SBio
10.1.9 Allergan
10.1.10 Alvartis
10.2 Biosimilar Monoclonal Antibody Sales Date of Major Players (2017-2020e)
10.2.1 Biocon
10.2.2 Accord Healthcare
10.2.3 AET Biotech
10.2.4 Amgen
10.2.5 Celltrion
10.2.6 Reddy's Laboratories
10.2.7 Hospira
10.2.8 3SBio
10.2.9 Allergan
10.2.10 Alvartis
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Biosimilar Monoclonal Antibody Product Type Overview
Table Biosimilar Monoclonal Antibody Product Type Market Share List
Table Biosimilar Monoclonal Antibody Product Type of Major Players
Table Brief Introduction of Biocon
Table Brief Introduction of Accord Healthcare
Table Brief Introduction of AET Biotech
Table Brief Introduction of Amgen
Table Brief Introduction of Celltrion
Table Brief Introduction of Reddy's Laboratories
Table Brief Introduction of Hospira
Table Brief Introduction of 3SBio
Table Brief Introduction of Allergan
Table Brief Introduction of Alvartis
Table Products & Services of Biocon
Table Products & Services of Accord Healthcare
Table Products & Services of AET Biotech
Table Products & Services of Amgen
Table Products & Services of Celltrion
Table Products & Services of Reddy's Laboratories
Table Products & Services of Hospira
Table Products & Services of 3SBio
Table Products & Services of Allergan
Table Products & Services of Alvartis
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Biosimilar Monoclonal Antibody Market Forecast (Million USD) by Region 2021f-2026f
Table Global Biosimilar Monoclonal Antibody Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Biosimilar Monoclonal Antibody Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Biosimilar Monoclonal Antibody Market Forecast (Million USD) Share by Demand 2021f-2026f